Trovagene (TROV) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
TrovaGene (TROV) PT Raised to $7 at Piper Jaffray
March 13, 2015 7:05 AM EDTPiper Jaffray analyst William Quirk reiterated an Overweight rating and lifted his price target on TrovaGene (NASDAQ: TROV) to $7.00 (from $6.25) following Q4 results.
Quirk commented, "Trovagene reported 4Q14 results, with revenue of $56K in line with our $53K estimate; Street (two... More



